Z. Dong

发表

The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma

Jinghui Dong, Z. Zeng, Yinyin Li, 2019, Artificial cells, nanomedicine, and biotechnology.

Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8+ T cell response and better prognosis in HBV‐related hepatocellular carcinoma

Yinying Lu, Chun-ping Wang, Hongbo Wang, 2017, Experimental cell research.

MARCH6 promotes hepatocellular carcinoma development through up-regulation of ATF2

Deyuan Zhang, Yinying Lu, Hongfei Liu, 2021, BMC cancer.

Chinese military medical teams in the Ebola outbreak of Sierra Leone

Z. Sun, S. Yu, J. Ji, 2016, Journal of the Royal Army Medical Corps.

Efficacy and safety of percutaneous cryoablation for elderly patients with small hepatocellular carcinoma: A prospective multicenter study

Fu-sheng Liu, Xiujuan Chang, Yan Chen, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial

W. Lu, J. Chen, Liang Chen, 2014, Trials.

Protective effect of the total flavonoids from Apocynum venetum L. on carbon tetrachloride-induced hepatotoxicity in vitro and in vivo

Yinying Lu, Jian-hui Qu, Z. Zeng, 2018, Journal of Physiology and Biochemistry.

LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells

Jun‐liang Fu, Yunfeng Zhu, Qinglei Zeng, 2018, Cancer management and research.

Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis

Yinying Lu, Z. Zeng, Xiujuan Chang, 2018, Medical science monitor : international medical journal of experimental and clinical research.

Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker

Y. Zhang, Yu Zhang, Xuefeng Zhang, 2022, Hepatology International.

Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma

Hong Wang, Yinying Lu, Jian-hui Qu, 2015, Hepatology.

Tumour seeding after percutaneous cryoablation for hepatocellular carcinoma.

Hong Wang, Yinying Lu, Jian-hui Qu, 2012, World journal of gastroenterology.

Protective effect of the total flavonoids from Apocynum venetum L. on carbon tetrachloride-induced hepatotoxicity in vitro and in vivo

Yinying Lu, Jian-hui Qu, Z. Zeng, 2018, Journal of Physiology and Biochemistry.

Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B

Liang Chen, Yongping Chen, Xiaodong Wang, 2021, The American journal of gastroenterology.

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B

Zu-Jiang Yu, Xiujuan Chang, Yan Chen, 2019, World journal of gastroenterology.

A novel nomogram to predict evident histological liver injury in patients with HBeAg-positive chronic hepatitis B virus infection

Liang Chen, Yongping Chen, Xiaodong Wang, 2021, EBioMedicine.

MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation.

Xiao-dong Guo, Zhiwei Li, Yinying Lu, 2017, Biochemical and biophysical research communications.

Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

C. Lei, Liang Chen, Yongping Chen, 2020, The Journal of infectious diseases.

Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma

Haiyang Li, R. Safadi, Yinying Lu, 2019, Hepatology.

Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels

Lele Song, Jiamin Cheng, Yinying Lu, 2021, Journal of hepatocellular carcinoma.

The expression level and diagnostic value of microRNA-22 in HCC patients

Jinghui Dong, Yinying Lu, Z. Zeng, 2020, Artificial cells, nanomedicine, and biotechnology.

Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B.

Jing Wang, Jia-bo Wang, Yongping Yang, 2022, Journal of hepatology.

Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria

Hong Wang, Yinying Lu, Jian-hui Qu, 2015, PloS one.

Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients

Jiyuan Zhang, Fu-Sheng Wang, G. Teng, 2015, International Journal of Infectious Diseases.

High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma

Hong Wang, Yinying Lu, Jian-hui Qu, 2013, Journal of Translational Medicine.

A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B

Minghua Deng, W. Lu, X. Qi, 2019, Clinical and translational gastroenterology.

Cryotherapy for cirrhosis-based hepatocellular carcinoma: a single center experience from 1595 treated cases

Yinying Lu, Jian-hui Qu, Z. Zeng, 2015, Frontiers of Medicine.

Age independent survival benefit for patients with small hepatocellular carcinoma undergoing percutaneous cryoablation: A propensity scores matching study

Jiashen Shao, Z. Zeng, Xiujuan Chang, 2023, Frontiers in Oncology.

Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma

Yinying Lu, Jian-hui Qu, Z. Zeng, 2015, Hepatology.